Navigation Links
Diplomat's 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
Date:7/17/2008

SWARTZ CREEK, Mich., July 17 /PRNewswire/ -- Diplomat Specialty Pharmacy, the nation's largest independent specialty pharmacy, released today results of their Spring 2008 Patient Satisfaction Survey. The national survey was mailed to 1500 patients, randomly selected from its own database of approximately 7500 patients. Without any offer of incentive, 568 surveys were returned to Diplomat, representing a very impressive 38% response rate.

Survey Says ...

-- 99% of patients are "satisfied" with Diplomat services, including a substantial 89% who are "very satisfied."

-- 98% of patients feel Diplomat meets their expectations "Most of the time," including a significant 86% who replied "All of the time."

-- 99% of patients say, "yes" they would recommend Diplomat to their family, friends and co-workers looking for a pharmacy.

"35 years ago Diplomat Specialty Pharmacy was built on personalized care, one patient at a time," said Phil Hagerman, President and CEO of Diplomat. "It is rewarding to know that we are successful because we still put our patients first. I congratulate all Diplomat employees whose high-touch patient care approach has led to industry leading patient satisfaction levels."

Diplomat contracted with Jarman-Johnson Communications and Gartner & Associates LLC to assist with survey analysis. The sampling error associated with a completed sample of 568 ranges from 0.8% to 4.1% at the 95% confidence level.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also s
'/>"/>

SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
2. CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina
3. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
4. Patients Who Bring Health Information from the Internet Get More Time with Doctor
5. National ePrescribing Patient Safety Initiative Supports Senates Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety
6. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
7. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
8. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
9. Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007
10. New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
11. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... , WELLINGTON, Colo., Nov. 5 ...e dog towns in the western U.S. This rare carnivo...ery susceptible to plague and often entire populat...Wildlife Service (FWS) has implemented a ferret br...tive ferrets into their formerly native habitat. ...
(Date:11/5/2009)... , RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire...), a leading supplier of innovative products for p...rted results for the first quarter of fiscal 2010....he Company reported revenues of $5.2 million, a 15... the first quarter a year ago. The Company said th...
(Date:11/5/2009)... , LYNBROOK, N.Y., Nov. 5 /PRNewswire-FirstCa...STC ), a biopharmaceutical company developing firs...nced its financial results for the third quarter e... happy that, in September of this year, the FDA,s ...ed, by a vote of 12-0, the approval of XIAFLEX(TM)...
(Date:11/5/2009)... , SAN DIEGO, CA, November 5, 2009 /PRNewswir...company focused on using proprietary taste recepto...edients for the food, beverage, and ingredient sup...and reported financial results for the third quart...illion for the third quarter of 2009, compared to ...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...sdaq: SUPG ), a pharmaceutical company dedicated ...herapies, today announced that it will release,its...November 4, 2008.,SuperGen,s management team will ... and any revised outlook for the future., A press...ediately,following the close of the market on Nove...
...6th Annual Meeting -, PRINCETON, N.J. and ANNAPOL...a leading monoclonal antibody company, and,PharmAt...eloping medical,countermeasures against biological...m a pilot study showing that the anthrax anti-toxi...mpared to a control group in a,therapeutic animal ...
... global demand for health economi...ston Healthcare Associates, Inc.,today announced t...Mr. Barak brings 16 years of pricing and reimburse...l pricing and reimbursement strategies,for drugs, ...f therapeutic,areas including oncology, pulmonary ...
Other Biology Technology:SuperGen to Announce 2008 Third Quarter Financial Results November 4, 2008 2Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 2Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 3Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 4Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 5Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 6Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 7Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability 2
(Date:11/4/2009)..., LEADS: (top news in natural science) , Uni...States uses less water today than it did 35 years ...lines in water use are partly attributable to alte...fficient irrigation systems. According to the late... used in the United States goes to cooling thermoe...
(Date:11/4/2009)... St. Louis, MO, November 4, 2009 Childhood obesit...tions. With more than one fourth of advertising on...s and beverages and continuing questions about the...November/December issue of the Journal of Nutriti...tising aimed at children might be a large contribu...
(Date:11/4/2009)... The Singapore laboratory that deciphered the DNA ...h) and elephant shark, has joined The Genome 10K P...able repository of DNA sequences on 10,000 species...a scale that currently can not be achieved. , Pa...n a paper published in the Nov. 5, 2009 issue of t...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Singapore scientists join international study of 10,000 vertebrates' genomes 2GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 1GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 2GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 3GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 4Saving Lives Is a Growth Industry 55875 1Saving Lives Is a Growth Industry 55875 2Saving Lives Is a Growth Industry 55875 3Expanded insurance benefits break down barriers to hospice care according to new study 55872 1Expanded insurance benefits break down barriers to hospice care according to new study 55872 2
... Virginia (Dec. 11, 2007) A quick and cool way to...ww.conservation.org/carboncalculator . , Lively v...tion Internationals (CI) new online carbon calcula...they are adding to global greenhouse gases. The C...missions by helping protect tropical forests from ...
...ING, Mich. Michigan State Universitys panda habit...ins of data aimed at understanding and saving gian...ch crucial data thats black, white and furry. , V...y, remote mountains of the Sichuan Province of Chi... hoping to capture, collar and track up to four wi...
...I, DECEMBER 10, 2007 Scientists at Punjab Agricult...nstitute, and Virginia Tech have been successful i...a using site-specific nutrient management strategi...percent of the Indian rice production, is currentl... as compared to the yield growth rate during the g...
Other Biology News:New carbon calculator conserves forests 2To catch a panda 2Researchers combat slowing yields with targeted fertilizer applications 2
Mouse Anti-Human QDPR Monoclonal Antibody, Unconjugated, Clone 2D4-1D3 from Novus Biologicals
Rabbit Anti-Conjugated Quinaldic Acid Polyclonal Antibody, Unconjugated from Advanced Targeting Systems
F10 Tubing Kit from Bio-Rad
...96 x 0.2 ml tubes or a 96-well microplate. Hot Bon... height and pressure to tightly seal PCR vessels f...iform, accurate temperatures with NIST-traceable c...C per second. Cycler comes with 8 preprogrammed pr...
Biology Products: